Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H11N3 |
| Molecular Weight | 137.1823 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NC1=NC=CC=N1
InChI
InChIKey=FTCYIGBVOHNHCD-UHFFFAOYSA-N
InChI=1S/C7H11N3/c1-6(2)10-7-8-4-3-5-9-7/h3-6H,1-2H3,(H,8,9,10)
| Molecular Formula | C7H11N3 |
| Molecular Weight | 137.1823 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Isaxonine (N-isopropyl-amino-2-pyrimidine orthophosphate) is able to accelerate nerve regeneration and functional recovery. Isaxonine has specific affinity for peripheral nerves. It acts directly on the neuron or indirectly by stimulating the production of a growth factor remains unknown. It demonstrates activity in the treatment of neuropathies of various etiology. Isaxonine treatment may be associated with hepatotoxicity.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Presence of covalently bound metabolites on rat hepatocyte plasma membrane proteins after administration of isaxonine, a drug leading to immunoallergic hepatitis in man. | 1989-05 |
|
| Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. | 1985-09-01 |
|
| [Protective effect of isaxonine against vincristine-induced neuropathy (author's transl)]. | 1982-04-08 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:33:26 GMT 2025
by
admin
on
Mon Mar 31 18:33:26 GMT 2025
|
| Record UNII |
883G6DMT63
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C542
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
71169
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
C020375
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
SUB08306MIG
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
883G6DMT63
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
100000083360
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
4214-72-6
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
C65969
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
m249
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | Merck Index | ||
|
1485
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
DTXSID20194975
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
CHEMBL1740513
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
760406
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY | |||
|
4501
Created by
admin on Mon Mar 31 18:33:26 GMT 2025 , Edited by admin on Mon Mar 31 18:33:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |